93 related articles for article (PubMed ID: 16872071)
1. Fundamental form of a population TCP model in the limit of large heterogeneity.
Carlone MC; Warkentin B; Stavrev P; Fallone BG
Med Phys; 2006 Jun; 33(6):1634-42. PubMed ID: 16872071
[TBL] [Abstract][Full Text] [Related]
2. A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity.
Roberts SA; Hendry JH
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):689-99. PubMed ID: 9635721
[TBL] [Abstract][Full Text] [Related]
3. Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy.
Her EJ; Reynolds HM; Mears C; Williams S; Moorehouse C; Millar JL; Ebert MA; Haworth A
Phys Med Biol; 2018 Jun; 63(13):135011. PubMed ID: 29799812
[TBL] [Abstract][Full Text] [Related]
4. Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression.
Fenwick JD
Phys Med Biol; 1998 Aug; 43(8):2159-78. PubMed ID: 9725596
[TBL] [Abstract][Full Text] [Related]
5. Analytic investigation into effect of population heterogeneity on parameter ratio estimates.
Schinkel C; Carlone M; Warkentin B; Fallone BG
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1323-30. PubMed ID: 17884301
[TBL] [Abstract][Full Text] [Related]
6. Impact of tumor repopulation on radiotherapy planning.
Wang JZ; Li XA
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):220-7. PubMed ID: 15629615
[TBL] [Abstract][Full Text] [Related]
7. A TCP model incorporating setup uncertainty and tumor cell density variation in microscopic extension to guide treatment planning.
Jin JY; Kong FM; Liu D; Ren L; Li H; Zhong H; Movsas B; Chetty IJ
Med Phys; 2011 Jan; 38(1):439-48. PubMed ID: 21361212
[TBL] [Abstract][Full Text] [Related]
8. Modeling tumor control probability for spatially inhomogeneous risk of failure based on clinical outcome data.
Lühr A; Löck S; Jakobi A; Stützer K; Bandurska-Luque A; Vogelius IR; Enghardt W; Baumann M; Krause M
Z Med Phys; 2017 Dec; 27(4):285-299. PubMed ID: 28676371
[TBL] [Abstract][Full Text] [Related]
9. The use of TCP based EUD to rank and compare lung radiotherapy plans: in-silico study to evaluate the correlation between TCP with physical quality indices.
Chaikh A; Balosso J
Transl Lung Cancer Res; 2017 Jun; 6(3):366-372. PubMed ID: 28713681
[TBL] [Abstract][Full Text] [Related]
10. Modelling the effect of spread in radiosensitivity parameters and repopulation rate on the probability of tumour control.
Stavreva N; Stavrev P; Balabanova A; Nahum A; Ruggieri R; Pressyanov D
Phys Med; 2019 Jul; 63():79-86. PubMed ID: 31221413
[TBL] [Abstract][Full Text] [Related]
11. Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centers.
Roberts SA; Hendry JH
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1247-57. PubMed ID: 10613320
[TBL] [Abstract][Full Text] [Related]
12. Potential implications of the bystander effect on TCP and EUD when considering target volume dose heterogeneity.
Balderson MJ; Kirkby C
Int J Radiat Biol; 2015 Jan; 91(1):54-61. PubMed ID: 25004946
[TBL] [Abstract][Full Text] [Related]
13. Loss of local control due to tumor displacement as a function of margin size, dose-response slope, and number of fractions.
Selvaraj J; Uzan J; Baker C; Nahum A
Med Phys; 2013 Apr; 40(4):041715. PubMed ID: 23556885
[TBL] [Abstract][Full Text] [Related]
14. Derivation of the expressions for gamma50 and D50 for different individual TCP and NTCP models.
Stavreva N; Stavrev P; Warkentin B; Fallone BG
Phys Med Biol; 2002 Oct; 47(20):3591-604. PubMed ID: 12433122
[TBL] [Abstract][Full Text] [Related]
15. Inclusion of molecular biotherapies with radical radiotherapy: modeling of combined modality treatment schedules.
Jones B; Dale RG
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1025-34. PubMed ID: 10571212
[TBL] [Abstract][Full Text] [Related]
16. Comparison of fractionation schedules in the large heterogeneity limit.
Guerrero M
Med Phys; 2009 Apr; 36(4):1384-8. PubMed ID: 19472645
[TBL] [Abstract][Full Text] [Related]
17. Limitations of a TCP model incorporating population heterogeneity.
Warkentin B; Stavrev P; Stavreva NA; Fallone BG
Phys Med Biol; 2005 Aug; 50(15):3571-88. PubMed ID: 16030383
[TBL] [Abstract][Full Text] [Related]
18. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
D'Souza WD; Thames HD; Kuban DA
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1540-8. PubMed ID: 15050335
[TBL] [Abstract][Full Text] [Related]
19. The reduction of tumour control with increasing overall time: mathematical considerations.
Jones B; Dale RG
Br J Radiol; 1996 Sep; 69(825):830-8. PubMed ID: 8983587
[TBL] [Abstract][Full Text] [Related]
20. Biological optimization of heterogeneous dose distributions in systemic radiotherapy.
Strigari L; D'Andrea M; Maini CL; Sciuto R; Benassi M
Med Phys; 2006 Jun; 33(6):1857-66. PubMed ID: 16872093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
